[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-164902-en":3,"doc-seo-164902-105":30,"detail-sidebar-cat-1-en-105":90},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":11,"category_id":12,"category_name":13,"doc_title":14,"doc_description":15,"doc_content":16,"file_id":17,"file_url":18,"file_type":19,"file_size":20,"view_count":4,"is_deleted":4,"is_public":11,"is_downloadable":11,"audit_status":11,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":15,"update_tm":28,"read_time":29},164902,687208528416,"Cipher","https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc",1,18,"Letters","VIMA 2.0 Model Non-Disclosure Agreement - (2019 updated)","A template non-disclosure agreement for situations where a disclosing company shares confidential information with a receiving party to evaluate a proposed transaction, such as a potential investment. It sets out the definition and scope of confidential information, including allowed oral-to-written notice timing and various delivery formats. It also establishes confidentiality obligations, restricts unauthorized use and disclosure, and outlines common legal mechanics for managing confidential material during early-stage financing discussions in Singapore.","NON-DISCLOSURE AGREEMENT\n\u000fExplanatory Note\nThis model non-disclosure agreement assumes a company is providing confidential information about itself to a potential investor looking to invest in such company. The non-disclosure agreement should be entered into with the recipient before the distribution of the confidential information. For early stage financing rounds (including Series A financing rounds) it is common for VCs/other investors to not enter into non-disclosure agreements and instead enter into a term sheet with the company/founders directly, and the company would take this into account in deciding what information to provide to such investors. A non-disclosure agreement may however still be relevant where the investor is a strategic investor/ competitor.\n\u000fTABLE OF CONTENTS\nContents\t\t\t\t\t\t\t\t\t\t\t    Page\u0013 TOC \\o \"1-1\" \\h \\z \\u \u0014\n\u0013 HYPERLINK \\l \"_Toc113978508\" \u00141.\tConfidential Information\t\u0013 PAGEREF _Toc113978508 \\h \u00144\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978509\" \u00142.\tConfidentiality Obligations\t\u0013 PAGEREF _Toc113978509 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978510\" \u00143.\tRestrictive Covenants\t\u0013 PAGEREF _Toc113978510 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978511\" \u00144.\tAcknowledgements\t\u0013 PAGEREF _Toc113978511 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978512\" \u00145.\tDisclosure Due To Court Action\t\u0013 PAGEREF _Toc113978512 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978513\" \u00146.\tAnnouncements\t\u0013 PAGEREF _Toc113978513 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978514\" \u00147.\tAssignment\t\u0013 PAGEREF _Toc113978514 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978515\" \u00148.\tIndulgence, Waiver, etc.\t\u0013 PAGEREF _Toc113978515 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978516\" \u00149.\tRemedy\t\u0013 PAGEREF _Toc113978516 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978517\" \u001410.\tTerm\t\u0013 PAGEREF _Toc113978517 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978518\" \u001411.\tVariation\t\u0013 PAGEREF _Toc113978518 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978519\" \u001412.\tSeverance\t\u0013 PAGEREF _Toc113978519 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978520\" \u001413.\tCounterparts\t\u0013 PAGEREF _Toc113978520 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978521\" \u001414.\tRights of Third Parties\t\u0013 PAGEREF _Toc113978521 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978522\" \u001415.\tWhole Agreement\t\u0013 PAGEREF _Toc113978522 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978523\" \u001416.\tGoverning Law\t\u0013 PAGEREF _Toc113978523 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978524\" \u001417.\tDispute Resolution\t\u0013 PAGEREF _Toc113978524 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc113978525\" \u001418.\tProcess Agent\t\u0013 PAGEREF _Toc113978525 \\h \u00149\u0015\u0015\n\u0015\n\u000fNON-DISCLOSURE AGREEMENT\nThis Agreement is made on [●] between:\n[●] (Company Registration Number: [●]), a company incorporated under the laws of Singapore whose registered office is at [●] (the \"Disclosing Party\"); and\n[●] (Company Registration Number: [●]), a company incorporated under the laws of [●] whose registered office is at [●] (the \"Receiving Party\"),\n(collectively, the \"Parties\" and each, a \"Party\").\nWhereas:\nThe Receiving Party is considering [a potential investment in the Disclosing Party/ [●insert description of Proposed Transaction]] (the \"Proposed Transaction\").\nIt is envisaged that the Disclosing Party will disclose Confidential Information (as defined below) to the Receiving Party in connection with the Receiving Party's evaluation of the Proposed Transaction (the \"Purpose\").\nThe Confidential Information belongs to the Disclosing Party and the Receiving Party has agreed to enter into this Agreement and comply with the terms set out in this Agreement concerning the disclosure, use and protection of the Confidential Information.\nIt is agreed as follows:\nConfidential Information\nThe term \"Confidential Information\" for the purpose of this Agreement shall mean any and all information and materials relating to the [Disclosing Party]disclosed, furnished or communicated (whether orally, provided such oral information is reduced to writing within 30 days after disclosure, or in writing, machine readable form, text, drawings, photographs, graphics, designs, plans, presentations, on-site visits or any other form whatsoever) by the Disclosing Party (whether through any of the Disclosing Party's Re","cbCaihshTntmoO7O","https://ap.wps.com/l/cbCaihshTntmoO7O","docx",64222,11,"English","en",105,"# Confidential Information\n## Confidentiality Obligations\n## Restrictive Covenants\n## Acknowledgements\n## Disclosure Due To Court Action\n## Announcements\n## Assignment\n## Indulgence, Waiver, etc.\n## Remedy\n## Term\n## Variation\n## Severance\n## Counterparts\n## Rights of Third Parties\n## Whole Agreement\n## Governing Law\n## Dispute Resolution\n## Process Agent","[{\"question\":\"What is the purpose of this non-disclosure agreement?\",\"answer\":\"The receiving party evaluates a proposed transaction, such as a potential investment in the disclosing party, using the disclosed confidential information only for that purpose.\"},{\"question\":\"What qualifies as confidential information under the agreement?\",\"answer\":\"Confidential information includes all information and materials disclosed by the disclosing party in connection with the purpose, in any form, including oral information that is reduced to writing within 30 days.\"},{\"question\":\"What information is excluded from confidential information?\",\"answer\":\"Excluded items include information that becomes publicly available through no breach, is disclosed with prior written consent, is independently developed, or is lawfully received on a non-confidential basis from a third party not bound by confidentiality obligations.\"}]","VIMA 2.0 Model Non-Disclosure Agreement - (2019 updated) | DOCX",1788162954,4,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":14,"keywords":34,"description":15,"schema_data":35,"social_meta":85,"head_meta":87,"extra_data":89,"updated_unix":28},"vima-20-model-non-disclosure-agreement-2019-updated","",{"@graph":36,"@context":84},[37,53,67],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,51],{"item":41,"name":42,"@type":43,"position":11},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/template/","Template",2,{"item":49,"name":13,"@type":43,"position":50},"https://docshare.wps.com/template/letters/",3,{"item":52,"name":14,"@type":43,"position":29},"https://docshare.wps.com/template/vima-20-model-non-disclosure-agreement-2019-updated/164902/",{"url":52,"name":14,"@type":54,"author":55,"headline":14,"publisher":57,"fileFormat":60,"inLanguage":23,"description":15,"dateModified":61,"datePublished":61,"encodingFormat":60,"isAccessibleForFree":62,"interactionStatistic":63},"DigitalDocument",{"name":9,"@type":56},"Person",{"url":41,"name":58,"@type":59},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-08-31",true,{"@type":64,"interactionType":65,"userInteractionCount":4},"InteractionCounter",{"@type":66},"ViewAction",{"@type":68,"mainEntity":69},"FAQPage",[70,76,80],{"name":71,"@type":72,"acceptedAnswer":73},"What is the purpose of this non-disclosure agreement?","Question",{"text":74,"@type":75},"The receiving party evaluates a proposed transaction, such as a potential investment in the disclosing party, using the disclosed confidential information only for that purpose.","Answer",{"name":77,"@type":72,"acceptedAnswer":78},"What qualifies as confidential information under the agreement?",{"text":79,"@type":75},"Confidential information includes all information and materials disclosed by the disclosing party in connection with the purpose, in any form, including oral information that is reduced to writing within 30 days.",{"name":81,"@type":72,"acceptedAnswer":82},"What information is excluded from confidential information?",{"text":83,"@type":75},"Excluded items include information that becomes publicly available through no breach, is disclosed with prior written consent, is independently developed, or is lawfully received on a non-confidential basis from a third party not bound by confidentiality obligations.","https://schema.org",{"og:url":52,"og:type":86,"og:title":14,"og:site_name":58,"og:description":15},"article",{"robots":88,"canonical":52},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":91},[92,96,101,106,111,116,121,124,129],{"id":21,"doc_module":11,"doc_module_name":46,"category_name":93,"show_sort_weight":94,"slug":95},"Presentations",90,"presentations",{"id":97,"doc_module":11,"doc_module_name":46,"category_name":98,"show_sort_weight":99,"slug":100},12,"Resumes",80,"resumes",{"id":102,"doc_module":11,"doc_module_name":46,"category_name":103,"show_sort_weight":104,"slug":105},14,"Invoices",70,"invoices",{"id":107,"doc_module":11,"doc_module_name":46,"category_name":108,"show_sort_weight":109,"slug":110},15,"Posters",60,"posters",{"id":112,"doc_module":11,"doc_module_name":46,"category_name":113,"show_sort_weight":114,"slug":115},16,"Social Media",50,"social-media",{"id":117,"doc_module":11,"doc_module_name":46,"category_name":118,"show_sort_weight":119,"slug":120},17,"Forms",40,"forms",{"id":12,"doc_module":11,"doc_module_name":46,"category_name":13,"show_sort_weight":122,"slug":123},30,"letters",{"id":125,"doc_module":11,"doc_module_name":46,"category_name":126,"show_sort_weight":127,"slug":128},21,"Paper Templates",5,"papers-templates",{"id":130,"doc_module":11,"doc_module_name":46,"category_name":131,"show_sort_weight":4,"slug":132},158,"General","general-158"]